(Q51538012)

30 June 2019

title

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes. (English)

1 reference

30 June 2019

author

Frank L Visseren

2

1 reference

30 June 2019

Giuseppe Mancia

8

object named as

Giuseppe Mancia

1 reference

30 June 2019

5

Diederick E Grobbee

1 reference

30 June 2019

author name string

Joep van der Leeuw

1

1 reference

30 June 2019

Mark Woodward

3

1 reference

30 June 2019

Yolanda van der Graaf

4

1 reference

30 June 2019

Stephen Harrap

6

1 reference

30 June 2019

Michel Marre

9

1 reference

30 June 2019

Neil Poulter

10

1 reference

30 June 2019

publication date

1 September 2016

1 reference

30 June 2019

published in

Diabetologia

1 reference

30 June 2019

volume

59

1 reference

30 June 2019

issue

12

1 reference

30 June 2019

page(s)

2603-2612

1 reference

30 June 2019

Creative Commons Attribution 4.0 International

copyright license

start time

1 September 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00125-016-4082-5

0 references

cites work

Global estimates of diabetes prevalence for 2013 and projections for 2035.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Review: a gentle introduction to imputation of missing values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Calculating the number needed to treat for trials where the outcome is time to an event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Participatory surveillance of hypoglycemia and harms in an online social network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-4082-5

Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects

21 January 2018

1 reference

12 December 2020

Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-R

1 reference

12 December 2020

Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring

1 reference

12 December 2020

10.1007/S00125-016-4082-5

Identifiers

DOI

1 reference

30 June 2019

PMCID

6518074

1 reference

30 June 2019

PubMed ID

27586250

1 reference

30 June 2019